Idipharma is an Italian pharmaceutical company specialized in the formulation and commercialization of innovative specialty products. Founded in 1997 by Dr. Pietro Bottino, a knowledgeable pharmacist, the company focuses on developing and bringing to market innovative products targeting the damaging effects of radical species, which are a frequent cause of various health conditions.
Since its establishment, Idipharma has directed its research activities towards three therapeutic areas: Infertility, Urology, and Gynecology. This strategic focus showcases the company's commitment to addressing critical medical needs.
Although specific details about the latest investment and investors are not available, Idipharma's dedication to pioneering pharmaceutical solutions in crucial medical areas makes it an intriguing prospect for investors seeking opportunities in the pharmaceutical industry.